Transition from Clinical Trials to RWE in Psoriasis & Alopecia Areata

المقدمة

سجل الان

From Clinical Trials to RWE in PsO & AA

الأهداف

1. Discuss how real-world experience shapes clinical practice and informs practical treatment decision-making.
2. Highlight how real-world experiences with ixekizumab in patients with plaque psoriasis (PsO) compare with data from randomized controlled trials, and address knowledge gaps
3. Highlight how Highlight how real-world experiences with
baricitinib in patients with Alopecia Areata (AA) compare with data from randomized controlled trials, and address knowledge gaps

المتحدثين

Dr. Dana Alessa, MBBS

Assistant Professor and Consultant Dermatologist
King Saud bin Abdulaziz University for Health Sciences and Ministry of National Guard Health Affairs-Riyadh
Head of Scientific Committee-SSDDS and ADAM 

Dr. Yousef Binamer

MD,EMBA,FRCPC,DABD,FAAD
Chairman, Department of Dermatology at King Faisal Specialist Hospital and Research Centre, Riyadh

Dr Afaf Sheikh

Consultant Dermatologist
Head division of Dermatology, Department of Medicine
King Abdulaziz Medical City, Riyadh
Assistant Professor, King Saud Bin Abdulaziz University for Health Sciences